{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:06:33Z","timestamp":1789005993373,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K16505"],"award-info":[{"award-number":["19K16505"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00380-020-01612-1","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T08:02:37Z","timestamp":1588060957000},"page":"1316-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of electropharmacological effects of AVE0118 on the atria of chronic atrioventricular block dogs: characterization of anti-atrial fibrillatory action by atrial repolarization-delaying agent"],"prefix":"10.1007","volume":"35","author":[{"given":"Ryuichi","family":"Kambayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Hagiwara-Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Nunoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"1612_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/europace\/eun130","volume":"10","author":"I Savelieva","year":"2008","unstructured":"Savelieva I, Camm J (2008) Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace 10:647\u2013665","journal-title":"Europace"},{"key":"1612_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00210-004-0957-y","volume":"370","author":"H G\u00f6gelein","year":"2004","unstructured":"G\u00f6gelein H, Brendel J, Steinmeyer K, Str\u00fcbing C, Picard N, Rampe D, Kopp K, Busch AE, Bleich M (2004) Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels. Naunyn Schmiedebergs Arch Pharmacol 370:183\u2013192","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1612_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/FJC.0b013e31824e1b93","volume":"59","author":"A Burashnikov","year":"2012","unstructured":"Burashnikov A, Barajas-Martinez H, Hu D, Nof E, Blazek J, Antzelevitch C (2012) Atrial-selective prolongation of refractory period with AVE0118 is due principally to inhibition of sodium channel activity. J Cardiovasc Pharmacol 59:539\u2013546","journal-title":"J Cardiovasc Pharmacol"},{"key":"1612_CR4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.hrthm.2006.07.017","volume":"3","author":"A Oros","year":"2006","unstructured":"Oros A, Volders PG, Beekman JD, van der Nagel T, Vos MA (2006) Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block. Heart Rhythm 3:1339\u20131345","journal-title":"Heart Rhythm"},{"key":"1612_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/FJC.0b013e3181719b0c","volume":"52","author":"JW Ford","year":"2008","unstructured":"Ford JW, Milnes JT (2008) New drugs targeting the cardiac ultra-rapid delayed-rectifier current (IKur): rationale, pharmacology and evidence for potential therapeutic value. J Cardiovasc Pharmacol 52:105\u2013120","journal-title":"J Cardiovasc Pharmacol"},{"key":"1612_CR6","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1161\/01.CIR.0000143050.22291.2E","volume":"110","author":"Y Blaauw","year":"2004","unstructured":"Blaauw Y, G\u00f6gelein H, Tieleman RG, van Hunnik A, Schotten U, Allessie MA (2004) \"Early\" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation 110:1717\u20131724","journal-title":"Circulation"},{"key":"1612_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0008-6363(03)00543-1","volume":"60","author":"KJ Wirth","year":"2003","unstructured":"Wirth KJ, Paehler T, Rosenstein B, Knobloch K, Maier T, Frenzel J, Brendel J, Busch AE, Bleich M (2003) Atrial effects of the novel K+-channel-blocker AVE0118 in anesthetized pigs. Cardiovasc Res 60:298\u2013306","journal-title":"Cardiovasc Res"},{"key":"1612_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/europace\/eup328","volume":"12","author":"K Nishida","year":"2010","unstructured":"Nishida K, Michael G, Dobrev D, Nattel S (2010) Animal models for atrial fibrillation: clinical insights and scientific opportunities. Europace 12:160\u2013172","journal-title":"Europace"},{"key":"1612_CR9","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/bjp.2008.240","volume":"154","author":"A Sugiyama","year":"2008","unstructured":"Sugiyama A (2008) Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts. Br J Pharmacol 154:1528\u20131537","journal-title":"Br J Pharmacol"},{"key":"1612_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1254\/jjp.88.341","volume":"88","author":"A Sugiyama","year":"2002","unstructured":"Sugiyama A, Ishida Y, Satoh Y, Aoki S, Hori M, Akie Y, Kobayashi Y, Hashimoto K (2002) Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs. Jpn J Pharmacol 88:341\u2013350","journal-title":"Jpn J Pharmacol"},{"key":"1612_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1254\/jphs.FP0060945","volume":"103","author":"K Wang","year":"2007","unstructured":"Wang K, Takahara A, Nakamura Y, Aonuma K, Matsumoto M, Sugiyama A (2007) In vivo electropharmacological effects of amiodarone and candesartan on atria of chronic atrioventricular block dogs. J Pharmacol Sci 103:207\u2013213","journal-title":"J Pharmacol Sci"},{"key":"1612_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1254\/jphs.09061SC","volume":"110","author":"H Iwasaki","year":"2009","unstructured":"Iwasaki H, Takahara A, Nakamura Y, Satoh Y, Nagai T, Shinkai N, Sugiyama A (2009) Simultaneous assessment of pharmacokinetics of pilsicainide transdermal patch and its electropahrmacological effects on atria of chronic atrioventricular block dogs. J Pharmacol Sci 110:410\u2013414","journal-title":"J Pharmacol Sci"},{"key":"1612_CR13","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.1021\/acs.molpharmaceut.8b00785","volume":"15","author":"R Watanabe","year":"2018","unstructured":"Watanabe R, Esaki T, Kawashima H, Natsume-Kitatani Y, Nagao C, Ohashi R, Mizuguchi K (2018) Predicting fraction unbound in human plasma from chemical structure: improved accuracy in the low value ranges. Mol Pharm 15:5302\u20135311","journal-title":"Mol Pharm"},{"key":"1612_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cardiores.2006.11.024","volume":"73","author":"U Schotten","year":"2007","unstructured":"Schotten U, de Haan S, Verheule S, Harks EGA, Frechen D, Bodewig E, Greiser M, Ram R, Maessen J, Kelm M, Allessie M, Van Wagoner DR (2007) Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+\/Ca2+-exchange. Cardiovasc Res 73:37\u201347","journal-title":"Cardiovasc Res"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01612-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00380-020-01612-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-020-01612-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T23:38:23Z","timestamp":1619566703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00380-020-01612-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1007\/s00380-020-01612-1","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"16 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}